Cancer Neoantigens as Targets for Natural and Therapeutic Anti-Tumor Responses

This content requires opt in of marketing cookies.


Description: This webinar, presented by Dr. Robert Schreiber, addresses how mouse and human cancers have been used to identify therapeutically useful tumor neoantigens; how these neoantigens can form the basis for personalized cancer vaccines; and what additional forms of therapy are needed to optimize the therapeutic effects of personalized cancer vaccines.

Insert Note Here
Save Close Clear
Lab Timer

Remember me
Forgot your password? Reset Password
Request an Account